PEAK6 Investments’s Ionis Pharmaceuticals IONS Stock Holding History

PEAK6 Investments’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$4.01M	Buy	+100,000	New	+$4.65M	0.01%	1073
2024 Q2	–	Sell	-4,000	Closed	-$173K	–	3950
2024 Q1	$173K	Hold	4,000	–	–	﹤0.01%	3141
2023 Q4	$202K	Buy	+4,000	New	+$192K	﹤0.01%	3242
2022 Q4	–	Sell	-38,500	Closed	-$1.7M	–	4790
2022 Q3	$1.7M	Buy	+38,500	New	+$1.62M	0.01%	1710
2020 Q2	–	Sell	-34,500	Closed	-$1.63M	–	4575
2020 Q1	$1.63M	Buy	+34,500	New	+$1.92M	0.01%	1173
2019 Q4	–	Sell	-18,900	Closed	-$1.13M	–	3699
2019 Q3	$1.13M	Sell	18,900 -12,200	-39%	-$795K	0.01%	1673
2019 Q2	$2M	Sell	31,100 -44,200	-59%	-$3.12M	0.01%	1283
2019 Q1	$6.11M	Buy	75,300 +63,600	+544%	+$4.1M	0.04%	592
2018 Q4	$633K	Hold	11,700	–	–	﹤0.01%	2164
2018 Q3	$603K	Buy	+11,700	New	+$550K	﹤0.01%	2402

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

PEAK6 Investments's IONS Position: Q3 2024 in Review

PEAK6 Investments reduced its Ionis Pharmaceuticals (IONS) stake by 10% in Q3 2024, selling an estimated $69.8K and leaving 13,500 shares worth $541K. The position accounts for ﹤0.01% of the portfolio, ranked #2266.

PEAK6 Investments first reported a position in IONS in Q3 2018 and has held it in 14 quarters since. The position peaked at $3.24M in Q3 2019. 353 funds tracked by Wall St. Rank hold IONS as of Q3 2024.

PEAK6 Investments held 13,500 shares of Ionis Pharmaceuticals worth $541K as of Q3 2024.
PEAK6 Investments sold 1,501 Ionis Pharmaceuticals shares in Q3 2024, an estimated $69.8K.
Ionis Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2266 holding.
PEAK6 Investments first reported a position in Ionis Pharmaceuticals in Q3 2018 and has held it in 14 quarters since.
PEAK6 Investments's Ionis Pharmaceuticals position peaked at $3.24M in Q3 2019.
353 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.